Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Rockwell Medical, Inc. (RMTI)
Price$7.99Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69.3M | $101.5M | $83.6M | $72.8M | $61.9M | $62.2M | $61.3M | $63.4M | $57.3M | $53.3M | $55.4M | $54.2M | $52.4M | $49.8M | $49.0M | $59.6M | $54.7M |
| Gross profit | $11.7M | $17.5M | $8.7M | $4.1M | −$2.4M | $2.7M | $2.8M | −$1.6M | $3.7M | $6.8M | $8.9M | $8.5M | $6.7M | $6.7M | $5.6M | $9.9M | $7.9M |
| Gross margin | 16.89% | 17.23% | 10.41% | 5.60% | −3.91% | 4.38% | 4.63% | −2.50% | 6.46% | 12.67% | 16.15% | 15.77% | 12.71% | 13.43% | 11.52% | 16.56% | 14.41% |
| Research & development | $0 | $19,000 | $1.1M | $3.1M | $6.8M | $7.1M | $6.9M | $5.6M | $6.3M | $5.8M | $5.0M | $7.8M | $39.4M | $48.3M | $17.8M | $3.4M | $6.5M |
| Operating expenses | $16.4M | $16.9M | $15.4M | $20.9M | $27.9M | $31.1M | $37.4M | $30.9M | $29.6M | $27.0M | $24.0M | $26.1M | $53.7M | $61.0M | $27.3M | $12.7M | $13.4M |
| Operating income | −$4.7M | $608,000 | −$6.7M | −$16.8M | −$30.3M | −$28.4M | −$34.5M | −$32.4M | −$25.9M | −$20.2M | −$15.1M | −$17.6M | −$47.1M | −$54.3M | −$21.7M | −$2.9M | −$5.5M |
| Operating margin | −6.77% | 0.60% | −7.98% | −23.05% | −48.98% | −45.69% | −56.32% | −51.18% | −45.24% | −37.93% | −27.28% | −32.40% | −89.84% | −108.87% | −44.29% | −4.82% | −10.02% |
| EBITDA | −$2.5M | $2.8M | −$5.2M | −$16.2M | −$29.7M | −$27.6M | −$33.7M | −$31.8M | −$25.4M | −$19.4M | −$14.3M | −$16.6M | −$46.1M | −$53.2M | −$20.5M | −$1.5M | −$4.2M |
| EBITDA margin | −3.61% | 2.75% | −6.25% | −22.26% | −47.90% | −44.35% | −55.03% | −50.15% | −44.34% | −36.50% | −25.80% | −30.57% | −87.92% | −106.69% | −41.88% | −2.48% | −7.76% |
| Net income | −$5.3M | −$480,000 | −$8.4M | −$18.7M | −$32.7M | −$30.9M | −$34.1M | −$32.1M | −$25.9M | −$19.8M | −$14.4M | −$21.3M | −$48.8M | −$54.0M | −$21.4M | −$2.7M | −$5.5M |
| Net profit margin | −7.67% | −0.47% | −10.09% | −25.65% | −52.76% | −49.66% | −55.67% | −50.68% | −45.24% | −37.16% | −26.05% | −39.36% | −93.13% | −108.38% | −43.79% | −4.51% | −10.05% |
| Basic EPSper basic share | -$1.50 | -$0.30 | -$3.70 | -$13.10 | -$38.30 | -$501.11 | -$684.44 | -$745.56 | -$623.33 | -$476.67 | -$354.44 | -$635.56 | -$1,808.89 | -$3,238.89 | -$1,478.89 | -$195.56 | -$452.22 |
| Diluted EPSper diluted share | -$1.50 | -$0.30 | -$3.70 | -$13.10 | -$38.30 | -$501.11 | -$684.44 | -$745.56 | -$623.33 | -$476.67 | -$354.44 | -$635.56 | -$1,808.89 | -$3,238.89 | -$1,478.89 | -$195.56 | -$452.22 |
Owners
Reported shareholders
≈89.56%of listed shares
Irrevocable Larson Family Investment Trust3.56M shares · Apr 11, 2025
View holders
| Holder | % owned |
|---|---|
Irrevocable Larson Family Investment Trust | ≈89.56%3.56M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 30.96%1.23M shares |
GEODE CAPITAL MANAGEMENT, LLC | 9.17%364.06K shares |
RENAISSANCE TECHNOLOGIES LLC | 9.06%359.67K shares |
Strobeck Mark | ≈8.14%323.49K shares |
JANE STREET GROUP, LLC | 6.17%245.23K shares |
VANGUARD FIDUCIARY TRUST CO | 5.86%232.66K shares |
TIMMINS MEGAN C. | ≈4.09%162.41K shares |
Wealthspire Advisors, LLC | 3.82%151.84K shares |
RAVICH MARK H | ≈3.80%151.1K shares |
BlackRock, Inc. | 3.64%144.76K shares |
Radie Robert S | ≈3.61%143.53K shares |
Nissenson Allen | ≈3.59%142.6K shares |
Smiley Andrea Heslin | ≈3.58%142.06K shares |
COOPER JOHN G | ≈3.53%140.37K shares |
Hunter Heather | ≈3.27%130.08K shares |
Chole Timothy | ≈3.09%122.86K shares |
Neri Jesse | ≈3.08%122.4K shares |
Lau Joan | ≈2.85%113.11K shares |
STATE STREET CORP | 2.54%100.9K shares |
Percentages use 3.97M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 2, 2026Form 4 · 10b5-1 | Hunter HeatherChief Operating Officer | SellCommon Stock | 2.9K | $0.84 | $2.4K | 132.5K |
| Jan 2, 2026Form 4 · 10b5-1 | Neri JesseSVP and CFO | SellCommon Stock | 886 | $0.84 | $744.24 | 124.8K |
| Nov 18, 2025Form 4 | COOPER JOHN GDirector | SellCommon Stock | 5.1K | $0.87 | $4.4K | 140.4K |
| Oct 1, 2025Form 4 · 10b5-1 | Hunter HeatherSVP, Chief Operating Officer | SellCommon Stock | 2.9K | $1.19 | $3.4K | 135.4K |
| Oct 1, 2025Form 4 · 10b5-1 | Chole TimothySVP and CCO | SellCommon Stock | 2.9K | $1.19 | $3.4K | 125.3K |